The store will not work correctly when cookies are disabled.
1-Ethyl-5-(3-thiophen-2-yl-allylidene)-2-thioxo-dihydropyrimidine-4,6-dione
ID: ALA4160028
PubChem CID: 145959390
Max Phase: Preclinical
Molecular Formula: C13H12N2O2S2
Molecular Weight: 292.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN1C(=O)/C(=C\C=C\c2cccs2)C(=O)NC1=S
Standard InChI: InChI=1S/C13H12N2O2S2/c1-2-15-12(17)10(11(16)14-13(15)18)7-3-5-9-6-4-8-19-9/h3-8H,2H2,1H3,(H,14,16,18)/b5-3+,10-7-
Standard InChI Key: WMPWPEDILCENGS-JEFLAVHQSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
15.6513 -7.0447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6513 -7.8597 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9435 -8.2713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2357 -7.8597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2357 -7.0447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9435 -6.6331 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9435 -9.0904 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5279 -6.6331 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3632 -6.6331 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.5279 -8.2713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8160 -7.8597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1083 -8.2713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4005 -7.8597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6536 -8.1952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1060 -7.5858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5135 -6.8780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3153 -7.0470 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.9435 -5.8140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6513 -5.4065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
1 9 2 0
10 11 1 0
11 12 2 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
13 17 1 0
12 13 1 0
4 10 2 0
18 19 1 0
6 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 292.39 | Molecular Weight (Monoisotopic): 292.0340 | AlogP: 1.95 | #Rotatable Bonds: 3 |
Polar Surface Area: 49.41 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.70 | CX Basic pKa: ┄ | CX LogP: 2.69 | CX LogD: 2.52 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.53 | Np Likeness Score: -1.92 |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |